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1 Summary 
The prevalence of obesity is on the rise in many parts of the world and so 
obesity-related disorders such as hypertension, dyslipidemia, diabetes mellitus 
and atherosclerosis. These diseases are the leading causes of chronic kidney 
and end-stage renal diseases. The metabolic changes in obesity are associated 
with an increased production of reactive oxygen species (ROS) which can 
damage DNA, cell components and disturb cell function. 
This study investigates the effects of high-fat diets on the expression of genes 
coding for prooxidant and antioxidant enzymes in the renal cortex of male 
C57BL/6 mice. Furthermore, it distinguishes between a diet high in animal fat 
(MFD, milk fat diet) and a diet high in plant fat (COD, coconut oil diet) and 
investigates if the effects of the animal-fat diet are reversible by normalizing the 
diet. The mice were fed for 30 weeks according to the specific dietary protocol. 
At the end of the treatment period, mRNA expression levels of the genes of 
interest were measured using real-time PCR.  
This work shows that the intake of high-fat diet (high in animal fat or plant fat) is 
associated with increased mRNA expression levels of genes coding for 
prooxidant and inflammatory enzymes. Specifically, the NAD(P)H-oxidase 
subunit Nox4 and the intercellular adhesion molecule-1 (ICAM-1) showed 
markedly increased expression levels. Additionally, an upregulation of the 
antioxidant system, particularly of the glutathione peroxidase-1 (Gpx1), in all 
mice with a higher fat intake was detected. No significant difference between 
the diet high in animal fat and the diet high in plant fat on the mRNA expression 
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levels of the investigated genes was seen. The effects of the animal fat diet are 
not reversible by diet normalization protocol used in this work. 
This study provides a possible molecular explanation for the increased oxidative 
stress and the increased inflammation in murine renal cortex observed after 
high-fat diet intake. 
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2 Introduction 
2.1 Obesity 
Obesity is a major public health problem in many parts of the world and it is a 
key factor in the development of various chronic diseases [1]. First known as a 
problem in developed countries, obesity is now dramatically on the rise in low- 
and middle-income countries, particularly in urban setting [2]. According to the 
World Health Organization (WHO), about 1.5 billion adults worldwide are 
overweight and of these, 500 million are obese. By 2015, approximately 2.3 
billion adults will be overweight and more than 700 million will be obese [1]. 
The most common way to define obesity is the body mass index (BMI), which is 
determined by weight (kilograms, kg) divided by height squared (square meters, 
m2). The WHO defines a BMI equal to or greater than 25 as overweight and a 
BMI equal to or greater than 30 as obesity (Table 1) [3]. 
 
WHO classification Body mass index 
(kg/m2) 
Underweight 
Normal range 
Overweight 
Obesity 
    Obese class I 
    Obese class II 
    Obese class III 
< 18.50 
18.50 – 24.99 
≥ 25.00 
≥ 30.00 
30.00 – 34.99 
35.00 – 39.99 
≥ 40 
 
Table 1. WHO classification of underweight, overweight and obesity according to BMI (adapted 
from [3]) 
Introduction 
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Other approaches to quantify obesity include anthropometry (skinfold 
thickness), densitometry (underwater weighing), computer tomography (CT) or 
magnetic resonance imaging (MRI) and electrical impedance measurements 
[4,5]. As these methods are either less reproducible, more expensive or 
complicated, they are rarely used in clinical practice. Another more accepted 
approach is the waist-to-hip ratio. A ratio > 0.9 in women and a ratio > 1.0 in 
men are abnormal. This value is highly diagnostic because excess of abdominal 
fat is most tightly associated with the metabolic risk factors [5,6].  
Obesity is caused by an imbalance between the uptake rate and the 
consumption of calories [1,5]. Energy intake and metabolic rate are regulated by 
a complex interplay of hormonal and neuronal signals. A few rare appetite 
regulate disorders are known but cannot account for the endemic extent of 
obesity [5]. It can be interpret as the consequence of the global shift in diets 
towards increased intake of energy-dense foods in combination with a trend 
towards decreased physical activity [1]. 
 
2.1.1 Health consequences of obesity 
Obesity is a major cause of preventable illness and premature death worldwide 
[7]. Chronic diseases, such as cardiovascular diseases, diabetes, nonalcoholic 
steatohepatitis, musculoskeletal disorders and some cancers, are caused by 
obesity [1]. Hypertension, type 2 diabetes and the nonalcoholic steatohepatitis 
are the most prevalent ones [8-10]. 
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Hypertension 
Hypertension is a strong risk factor for stroke, left ventricular hypertrophy, heart 
failure, coronary heart disease, aortic aneurysm, aortic dissection, renal failure 
and retinopathy [6,11]. 
The European Society of Cardiology (ESC) defines hypertension as a systolic 
blood pressure level above 140 mmHg in combination with a diastolic blood 
pressure level above 90 mmHg. As shown in table 2, the ESC classifies 
hypertension in 3 different grades [12]. 
The incidence of hypertension correlates with the age and with the grade of 
obesity [11,13]. About 50% of people older than 60 years develop hypertension, 
in combination with obesity even about 75%. This is supported by the fact that a 
reduction of 10 kg body weight leads to a 10-15 mmHg lower systolic blood 
pressure [11].  
Hypertension is a consequence of a higher cardiac output and higher peripheral 
resistance [11]. Obesity influences the development of hypertension in several 
ways: Higher body mass leads to an increased blood volume and therefore to a 
higher cardiac output. Vasoconstriction caused by obesity is associated with an 
increased sympathetic nervous system tone. The elevated insulin levels causes 
an insulin-mediated salt retention which is accompanied by increased blood 
volume [5]. 
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Blood pressure 
mmHg 
Systolic Diastolic 
Optimal 
Normal 
High Normal 
Hypertension 
Grade 1 
Grade 2 
Grade 3 
 
Isolated systolic  
Hypertension 
< 120 
< 130 
130-139 
 
140-159 
160-179 
≥ 180 
 
 
≥ 140 
< 80 
< 85 
85-89 
 
90-99 
100-109 
≥ 110 
 
 
< 90 
 
Table 2. ESC definitions and classifications of blood pressure levels (adapted from [12]). 
 
Type 2 diabetes 
In the 1970 the term “diabesity” was created because of the close relationship 
between obesity and type 2 diabetes mellitus [14]. About 90% of individuals 
which develop type 2 diabetes mellitus, have a BMI >23 [13]. Especially excess 
of intraabdominal fat is strongly linked to the development of insulin resistance. 
Different mechanisms are involved in the pathogenesis of insulin resistance in 
combination with obesity: Elevated insulin level in plasma induces insulin-
receptor downregulation. Increased level of free fatty acids in plasma leads to 
an impaired insulin action. Intracellular lipid accumulation and cytokines like 
TNF-α, interleukin 6, adiponectin and resistin produced by adipocytes, reduce 
the insulin-sensitivity of cells [5,15]. 
The majority of cases of the type 2 diabetes develop from a constellation of 
metabolic abnormalities including central adipositas, hypertriglyceridemia, low 
high-density lipoprotein (HDL) cholesterol and hypertension [11]. These 
Introduction 
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metabolic abnormalities are summarized in the term metabolic syndrome 
(syndrome X, insulin resistance syndrome) [5]. 
 
Nonalcoholic steatohepatitis (NASH) 
The nonalcoholic steatohepatitis is defined as a necroinflammatory disorder, 
ultimately leading to liver fibrosis and cirrhosis [10]. 
NASH is closely connected with obesity, type 2 diabetes and the metabolic 
syndrome [10,16]. About 10% to 24% of the population in various countries has 
nonalcoholic fatty liver disease. In obese persons (BMI > 30), the prevalence 
can be increased by 57% to 74%. About 19% of obese people will develop 
NASH [17]. 
NASH develops out of a nonalcoholic fatty liver disease (NAFLD) [10]. In a first 
step, an accumulation of triglycerides in hepatocytes causes NAFLD. In a 
second step, the infiltration of inflammatory cells like neutrophile granulocytes 
and monocytes results in steatohepatitis [16,18]. In contrast to NASH, NAFLD is 
reversible by reduction in body fat and optimal diabetes control [18]. The 
histology of the NASH is similar to that of alcoholic liver disease, including fatty 
degeneration, ballooning of hepatocytes, necroinflammation and pericellular 
fibrosis [10]. 
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2.1.2 Adipose tissue, an active endocrine organ 
Adipose tissue is not only a passive energy store, but also an important 
endocrine organ which produces various cytokines. Some of them are tumor 
necrosis factor alpha (TNF-α), interleukin-6 or -8 (IL-6/8), angiotensin II (ATII) 
and monocyte chemotactic protein-1 (MCP-1). Therefore it is a source and a 
target of inflammatory processes [19,20]. Some of these secreted cytokines, 
like MCP-1 or IL-8, are well-characterized chemoattractants or activators of 
monocytes. In chronic state of obesity adipose tissue is infiltrated by immune 
cells of the monocyte/macrophage lineage [21,22]. TNF-α which is secreted 
from adipocytes and also from macrophages leads to adipocyte lipolysis and is 
involved in the genesis of inflammation [23,24] . Additionally, high plasma TNF-
α levels are associated with insulin resistance, endothelial cell dysfunction, high 
C-reactive protein concentration and it promotes inflammatory and fibrotic 
processes in the kidney [19]. 
Metabolic changes such as hyperglycemia, hyperlipidemia and elevated 
inflammatory cytokines induced by obesity, elevate metabolic and inflammatory 
stress (Figure 1) [25]. Key enzyme of the cellular reactive oxygen species 
(ROS) production is the prooxidative enzyme nicotinamide adenine dinucleotide 
phosphate oxidase (NAD(P)H oxidases) which is increased in the adipose 
tissues of obese subjects (Figure 1) [25,26]. Oxidative stress plays a major role 
in the pathogenesis of endothelial dysfunction, hypertension and insulin 
resistance [26,27]. 
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Figure 1. Metabolic changes in obesity like hyperglycemia, hyperlipidemia and inflammatory 
cytokines elevate metabolic and inflammatory stress. Mitochondrial dysfunction, polyol pathway, 
hexosamine pathway, advanced glycation end-product pathway and prooxidative enzymes NOS 
and NAD(P)H oxidases are involved in ROS production (adapted from [25]). 
  
Obesity 
 
Hyperglycemia Hyperlipidemia Inflammatory cytokines 
 
Mitochondrial dysfunction 
Polyol pathway 
Hexosamine pathway 
PKCs pathway 
AGE production 
 ROS 
Pro-inflammatory cytokines 
(TNFα, IL6, MCP1, etc.) 
Free fatty acids 
NF-κB pathway 
Insulin signaling pathway 
 
Oxidative stress 
NADPH oxidase 
Metabolic stress Inflammatory stress  
 
Insulin resistance 
Introduction 
13 
 
2.2 Suitability of mice as diet-induced obesity models 
To understand the etiology and the effects of obesity in humans and for the 
development of possible treatments, animals can be used as models [28].  
Because of the similar genetics to humans and genetic manipulation is readily 
attainable, the mouse is an established model in obesity research. Additionally, 
mice are small and easy to handle [28]. 
The male C57BL/6 mouse, also used in the present study, is the most 
commonly used animal model for diet-induced obesity research [29]. C57BL/6 
mice show a high susceptibility to diet-induced obesity and type 2 diabetes. Fed 
with high-fat diet C57BL/6 mice become obese, develop mild to moderate 
hyperglycemia and hyperinsulinemia [29].  
Introduction 
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2.3 The kidney 
2.3.1 Anatomy and function of the kidney 
The paired kidneys are located in the retroperitoneal space. The kidney of an 
adult is approximately 10-12 cm in length, 5-6 cm wide and 4 cm thick and has 
a weight of about 120-300 g. Each kidney consists of a convex and a concave 
surface resulting in it typical bean-shaped appearance. At the renal hilum, 
located at the concave side of the kidney, the renal artery enters and the renal 
vein and the ureter leave the organ [30]. Approximately 20% of the cardiac 
output receives the kidney. Therefore it is a well perfused organ [31]. The 
kidney has a smooth surface and is surrounded by the renal capsule (lat. 
Capsula fibrosa) which consists of tough fibrous tissue. 
Already macroscopically it is possible to differentiate the parenchyma of the 
kidney into two major structures: The central, deeper located renal medulla (lat. 
Medulla renalis) and the superficial located renal cortex (lat. Cortex renalis). 
The important functional structures of the kidney are the nephrons. A nephron 
consists of a renal corpuscle (lat. Corpusculum renale) and the corresponding 
section of the renal tubule system (lat. Tubulus renalis). The renal corpuscle is 
located in the cortex and consists of capillary tuft (lat. Glomerulus) which is 
surrounded by a double-walled capsule. Each capillary tuft is built by 30 to 40 
capillary-loops and is intercalated between the afferent arteriole and the efferent 
arteriole [30].  
The kidney has an important function in the control of a variety of complex 
physiologic processes [32]. One important task is the control of the solute and 
water secretion to maintain the volume and the osmolarity of the extracellular 
Introduction 
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space [33]. It has a high filtration rate and produces about 0.7 to 1.5 l urine per 
24 hours [31]. The kidney plays also an important role in the acid–base 
homeostasis by regulating the H+- and HCO3
- - secretion. Additionally, the 
kidney eliminates final products of the metabolism and removes drug 
metabolites, by conserving useful blood metabolites such as glucose or amino 
acids. Last but not least the endocrine function of the kidney, including the 
production of erythropoietin and calcitriol [32,33]. 
 
2.3.2 Effects of obesity on renal function and structure 
Obesity is a risk factor for the development of chronic kidney diseases and end-
stage renal disease in individuals with existing kidney disease [34].  
As mentioned above (chapter 2.1.1, Health consequences of obesity) obesity 
increases the chance of developing hypertension and type 2 diabetes, the major 
causes of chronic kidney diseases. Additionally, obesity is an independent risk 
factor for the onset and aggravation of chronic kidney diseases. It leads to an 
increased renal plasma flow and hence to an increase in glomerular filtration 
rate. The first clinical manifestation of this glomerular hyperfiltration is an 
increase in urinary excretion of albumin [34]. Furthermore, obesity induces 
histological changes like glomerulomegaly and focal segmental 
glomerulosclerosis [35]. Moreover, obesity increases vulnerability to the 
development of renal cell cancer, in men and women [36].  
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2.4 Prooxidant and proinflammatory enzymes 
2.4.1 Oxidative stress and role for prooxidant and inflammatory 
molecules in obesity 
 
Oxidative stress is caused by imbalance between tissue oxidants like free 
radicals or reactive oxygen species and antioxidants. Free radicals are highly 
reactive molecules with unpaired electrons that easily bind with surrounding 
molecules. Reactive oxygen species (ROS) are oxygen-containing molecules 
which can have unpaired electrons and are highly reactive in tissues. On the 
one hand low concentrations of free radicals and ROS are necessary for normal 
redox cell status, cell function and intracellular signaling. On the other hand, 
high concentrations of ROS can damage DNA, cell components and can disturb 
the cell function [37]. 
Different mechanisms, existing in obesity, such as  hyperglycemia, elevated 
free fatty acids in plasma and chronic low grade inflammation lead to oxidative 
stress [38]. 
 
Hyperglycemia 
Hyperglycemia activates several oxidative pathways. In state of hyperglycemia, 
an increased level of advanced glycosylation end products (AGE) occurs. AGEs 
are the result of non-enzymatic glycosylation of protein or lipid molecules. AGEs 
can trigger intracellular transcription factors and increase the expression of 
vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion 
molecule-1 (ICAM-1). Activation of these intracellular molecules leads to a 
higher ROS production [39]. Additionally, hyperglycemia increases the activity 
Introduction 
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of the nicotinamide adenine dinucleotide phosphate oxidase (NAD(P)H oxidase) 
resulting in an increased ROS production [40]. 
 
Elevated plasma level of free fatty acids 
Elevated plasma level of free fatty acids (FFA) has an influence on the ROS 
production in different ways [38]. FFA elevate blood glucose level and produce 
nitroxide radicals in smooth vascular and endothelial cells. Furthermore, FFA 
can induce the oxidative burst in leucocytes and in this way increase the ROS 
production [41]. 
 
Chronic low grade inflammation 
The state of chronic low grade inflammation in obesity is associated with 
expression of inflammatory cytokines, production of C-reactive protein (CRP) 
and increased level of leucocytes [38]. As described above (chapter 2.1.2, 
Adipose tissue, an active endocrine organ) adipose tissue produces 
proinflammatory cytokines like IL-6 and TNF-α. Elevated inflammatory 
molecules stimulate the expression of adhesion molecules, such as intercellular 
adhesion molecule-1 (ICAM-1), and promote the migration and activation of 
monocytes [42]. This leads to an increased ROS production. The neutrophils, 
as a part of the leucocytes, elevate the ROS production via NADPH oxidase 
[43]. 
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2.4.2 NAD(P)H oxidases 
Nicotinamide adenine dinucleotide phosphate oxidase (NAD(P)H oxidases, 
(Nox)) are multi-subunit enzymes, which have been identified as a major source 
of reactive oxygen species (ROS) in vascular cells and in the kidney [44,45]. 
These enzymes catalyze the production of superoxide, which is a common 
progenitor of other ROS, according to the following reaction [44]. 
 
NAD(P)H +O2  NAD(P)
+ + H+ + O2
- 
 
The prototypical NAD(P)H oxidase Nox2 is that found in professional 
phagocytes such as neutrophils and monocytes/macrophages[44,46]. Figure 2 
shows the components of the NAD(P)H-oxidase, which includes the membrane-
integrated catalytic subunit Nox2 (also known as gp91phox), tightly associated 
with p22phox and the regulatory cytosolic proteins p47phox, p67phox and p40phox  
[46]. On stimulation, p47phox becomes phosphorylated and the cytosolic proteins 
form a complex that translocates to catalytic subunit [47]. The activation also 
requires participation of the small GTPase rac [46]. 
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Figure 2. Structure and function of the NAD(P)H-oxidase (adapted from [48]). 
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of ROS [51]. The importance of the enzyme is emphasized by the observation, 
that patients lacking functional Nox2 suffer from severe infections [51]. 
The non-phagocyte Nox4-enzyme (originally termed Renox) is highly expressed 
in the kidney, particularly in the proximal convoluted tubule cells of the renal 
cortex [52]. Nox4 may have a role as an oxygen sensor in the kidney and 
therefore a function as a regulator of the erythropoietin production [53]. 
The normally relatively low amount of ROS, produced by non-phagocyte 
NAD(P)H oxidase, is important in redox signaling in many cellular processes 
such as cell growth, apoptosis, migration and extracellular matrix remodeling 
[54,55]. For example, hormones, cytokines, oscillatory shear stress activate the 
non-phagocyte NAD(P)H oxidase resulting in increased ROS production[45]. As 
a consequence inflammation, hypertension, endothelial dysfunction and kidney 
failure occur [56]. In figure 3 the activation factors and the effects of the non-
phagocyte NAD(P)H oxidase are summarized 
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Figure 3. Activation factors and effects of non-phagocyte NAD(P)H oxidase (adapted from [56]). 
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2.4.3 Intercellular adhesion molecule-1 
Intercellular adhesion molecule-1 (ICAM-1) is a cell surface glycoprotein and a 
member of the immunoglobulin superfamily [57,58]. It is expressed 
constitutively or under conditions of inflammation in a variety of cells, including 
endothelial cells, parenchymal cells, hepatocytes, adipose tissue and cardiac 
myocites [59]. In response to inflammatory stimuli ICAM-1 works as a leukocyte 
adhesion receptor and mediates migration of leukocytes into tissues [60].  
ICAM-1 plays a critical role in the development of diabetic nephropathy [61,62]. 
Hyperglycemia, advanced glycation endproducts and oxidative stress are 
elements of the diabetic state which induce ICAM-1 upregulation [63-65]. ICAM-
1 upregulation leads to an increased accumulation of macrophages in the 
kidney which accelerates the development of diabetic glomerulosclerosis by 
producing various types of cytokines which stimulate cell proliferation and 
increase the expression of extracellular matrix proteins [61]. 
A soluble form of ICAM-1 (sICAM-1), the extracellular domain of the 
glycoprotein after proteolytic cleavage at the cell surface, is found in the 
systemic circulation [66]. The function of sICAM-1 is unclear but it is a marker of 
inflammation and may play a modulating role in inflammation [67].  
Several studies in humans have shown that obesity, especially central 
adipositas, leads to elevated sICAM-1 plasma levels [68]. 
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2.4.4 Monocyte chemotactic protein-1 
Based on structural and genetic criteria the monocyte chemotactic protein-1 
(MCP-1) forms together with MCP-2 and -3 a subfamily of the β-chemokines 
[69,70]. Chemokines are a large family of chemoattractants that direct migration 
of leukocytes from blood to sites of inflammation [71]. MCP-1 is a monocyte-
specific chemoattractant and activator and is produced by a variety of cells on 
stimulation with cytokines or bacterial and viral products [69]. Very potent 
endogenous inducers of MCP-1, especially for mononuclear cells, fibroblasts, 
endothelial and epithelial cells, are the cytokines IL-1, TNF-α and interferon-γ 
[72,73].  
A variety of inflammatory diseases, old age, cigarette smoking and obesity are 
correlated with higher serum MCP-1 levels [69,74]. Several studies have 
suggested that MCP-1 is involved in the development of atherosclerosis and 
higher levels of MCP-1 have been correlated with an increased risk of 
myocardial infarction [75,76]. Additionally, MCP-1 plays a critical role in 
inflammation of the kidney and it promotes the development of diabetic 
nephropathy [77]. 
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2.5 Antioxidant Enzymes 
2.5.1 Superoxide dismutase 
Superoxide dismutases (SOD) are enzymes which catalyze the conversion of 
the highly reactive radical O2
- into the more stable hydrogen peroxide (H2O2) in 
the following way [78]: 
2 O2
- + 2 H+  H2O2 + O2 
Three different isoforms of SOD are known: The copper- and zinc-containing 
homodimer SOD1 (also known as CuZn-SOD) which is localized in the cytosol, 
the homotetramer SOD2 (also known as Mn-SOD) which has manganese (Mn) 
as cofactor and is localized in mitochondria and the copper- and zinc-containing 
homotetramer SOD3 (also known as EC-SOD) which is localized in the 
extracellular space [79].  
All three isoforms are expressed in the healthy kidney [80,81]. SOD1 and SOD3 
are the predominant isoforms in blood vessels and play an important role in 
regulation of basal O2
- levels and endothelial function [82]. The expression of 
SOD1 can be upregulated by several different stimuli like shear stress [83], 
hydrogen peroxide [84] or nitric oxide [85], whereas hypoxia may down regulate 
SOD1 expression in certain tissues [86]. SOD3 expression can be upregulated 
by cytokines [87] and other vasoactive factors like histamine, vasopressin, 
oxitocyin, endothelin-1, serotonin or heparin [88]. The expression of SOD2 in 
blood vessels is relative low, but it plays a critical role in protection against 
mitochondrial damage during oxidative stress [82]. 
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2.5.2 Glutathion peroxidase 
Glutathion peroxidase (Gpx) is a soluble selenoprotein, which is expressed in 
most tissues and is essential for defense against oxidative stress. Gpx reduces 
H2O2 and organic hydroperoxides to H2O and corresponding alcohols, using 
reduced glutathione as an essential co-substrate, according to the following 
reaction [89]: 
H2O2+2GSH  2H20 + GSSG 
 
So far, four different Gpx isoenzymes, Gpx1 through Gpx4, have been 
identified. All isoforms contain selenocystein at their active side and a selenium-
dose dependent increase of Gpx1 expression has been shown [90,91].  
The intracellular Gpx1 is ubiquitously expressed in humans, being particularly 
abundant in endothelial cells, erythrocytes, kidney and liver [90,92]. Gpx1 is a 
key enzyme in protecting vessels against oxidative stress and atherogenesis 
and different studies show that a physiological level of laminar shear stress 
induces an upregulation of Gpx1 expression [89]. Furthermore, decreased Gpx1 
activity was observed in patients with coronary artery disease and in those with 
myocardial infarction [93]. 
The extracellular glutathione peroxidase Gpx3 is synthesized in various tissues; 
including heart, lung and placenta but the major source is the kidney, in 
particular the epithelial cells of the proximal tubules [90,92,94]. In this context, it 
has been hypothesized that Gpx3 may protect the proximal tubules of the 
kidney from localized peroxide-induced damage [90]. In contrast to Gpx1, Gpx3 
has activity against phospholipid hydroperoxides, which gives Gpx3 a direct role 
in protection of membrane integrity [95]. 
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2.5.3 Antioxidant-1 
Antioxidant-1 (Atox1) is a soluble cytosolic copper carrier protein termed copper 
chaperons. It delivers copper to some of the secretory copper enzymes via the 
trans-Golgi network [96,97]. Copper (Cu) is an essential, and due to its 
chemical redox potential and ability to participate in free radical reactions, also 
potentially a toxic metal [98].  
Additionally to Atox1, two other chopper chaperons have been identified: The 
Cu chaperone for cytochrome c oxidase (Cox1) which delivers copper to 
cytochrome c oxidase in the mitochondria and the Cu chaperone for superoxide 
dismutase (CCS) which delivers copper to SOD1 in the cytosol [99].  
SOD3 as a secretory protein obtains copper trough Atox1 and for full activity of 
SOD3, Atox1 is required. Atox1 is not only a copper chaperon for SOD3; but is 
also a positive regulator for SOD3 transcription. Together, Atox1 has an 
important role by modulating SOD3 in the defense against oxidative stress 
[100]. 
 
2.5.4 Nitric oxide synthases 
 
Nitric oxide synthases (NOS) are responsible for the synthesis of nitric oxide 
(NO) from L-arginine, which is described by the following equation [101,102]: 
 
L-arginine + NADPH + H+ + O2  NO + L-citrulline + 0.5 NADP
+ + H2O 
 
These enzymes work as homodimers and are involved in many physiological 
and pathological reactions [103]. Three different isoforms of nitric oxide 
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synthase are known: neuronal (nNOS or NOS1), originally identified as 
constitutive in neuronal tissue, inducible NOS (iNOS or NOS2), originally 
identified as being inducible by cytokines in macrophages and endothelial NOS 
(eNOS or NOS3), originally identified in vascular endothelial cells [104,105].  
The neuronal NO synthase NOS1 is Ca2+- and calmodulin-dependent and is 
constitutively expressed mainly in the brain but also in the peripheral neural 
systems, in skeletal muscle, in endothelial cells and also in the kidney where it 
may have a role in regulation of tubuloglomerular feedback [105-108]. Because 
of the expression in different tissues and the high activity in brain, NOS1 is 
responsible for the largest proportion of constitutive NO synthase activity [105].  
The inducible NO synthase NOS2 is, in contrast to NOS1 and NOS3, Ca2+- and 
calmodulin-independent and it is expressed in a wide range of cell types and 
tissues, also in the renal tubules and vasculature [105,109,110]. Inducible 
NOS2 is an inflammation-responsive enzyme that is upregulated in acute and 
chronic inflammation as part of host defense and the wound-healing process 
[111,112]. 
The endothelial NO synthase NOS3 is, like NOS1, Ca2+- and calmodulin-
dependent and it is constitutively expressed in endothelial cells, also in 
endothelial cells of renal vasculature and glomeruli and it plays a role in 
regulation of intrarenal vascular tone [105,113,114]. In contrast to the cytosolic 
NOS1 and NOS2, NOS3 is partially membrane-associated [104]. 
NO is a potent vasodilator and counters the effects of the renin-angiotensin, the 
sympathic nervous and other vasoconstrictor systems [115]. Additionally, NO 
reduces oxidative stress by scavenging ROS. By reducing oxidative stress, NO 
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inhibits the transcription of MCP-1 and VCAM-1, proteins with a central role in 
initiating inflammation of the vessel wall [116]. NO plays also an important role 
in maintaining renal function and structure and chronic NOS inhibition leads to 
renal injury [117]. 
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2.6 Aim of the study 
The aim of this study was to determine the effect of animal fat diet and plant fat 
diet on steady-state gene expression levels of genes regulating redox state and 
inflammation in the murine renal cortex. Specifically, the following questions 
were addressed: 
● What are the steady-state expression levels of Nox2, Nox4, p22phox, NOS2, 
NOS3, ICAM-1, MCP-1, Gpx1, Gpx3, SOD1, SOD3 and Atox1 in the kidneys of 
control animals with normal diet? 
● What is the effect of a 30 week treatment with high-fat diet of different 
sources (milk fat vs. coconut oil) on the renal expression of the investigated 
genes? 
● Is the effect of a 15 week treatment with a high fat diet on expression of 
indicated renal genes reversible by changing the diet back to normal diet? 
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3 Materials and methods 
3.1 Animals and diets 
The study was performed with healthy male C57BL/6 mice (Charles River, 
Sulzfeld Germany) which were housed at the institutional animal facilities on a 
12:12 h light-dark cycle. Animals had free access to food and water. All the 
experimental protocols and the institutional animal facilities were approved by 
the local authorities for animal research (Kommission für Tierversuche des 
Kanton Zürich, Switzerland). 
At the age of four weeks, the mice were randomized and assigned to four 
different treatment groups, the groups CD (control diet), COD (coconut oil diet), 
MFD (milk fat diet) and MFD/CD. In all four groups, the mice were fed for 30 
weeks according to a specific dietary protocol. In the control group, the mice 
were fed with the control diet (CD, Kliba Nafag 3430 Kaiseraugst Switzerland, 
12.3% of total kcal from fat), the mice in the COD group were fed with the 
coconut oil diet (COD, Research Diets D12331, 58% of total kcal from fat) and 
in the MFD group, the mice were fed with the milk fat diet (MFD, Research Diets 
D12079B New Brunswick NJ, 41% of total kcal from fat). The MFD/CD group 
included mice which were fed with the milk fat diet for 15 weeks followed by 
control diet for 15 weeks. With these diets, the study included a vegetable fat 
diet (= coconut oil diet) and an animal fat diet (= milk fat diet). Table 2 shows 
the macronutrient composition of the three different diets. 
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 CD COD MFD 
Fat 12.3 58 41 
Carbohydrate 65.4 25.5 43 
Protein 22.4 16.4 17 
Table 2. Exact composition of the diets used (in percent of kcal). 
 
After 30 weeks, at the end of the treatment period, all mice were fasted 
overnight, anesthetized (20 mg/kg body weight Xylazine, 100 mg/kg body 
weight Ketamine and 3.0 mg/kg body weight Acepromazine in 0.9% NaCl) and 
exsanguinated via cardiac puncture. Organs, which were later used to analyze 
RNA expression levels, were cleaned in RNA-later (Qiagen, Basel, 
Switzerland), snap-frozen in liquid nitrogen and stored at -80°C. 
 
3.2 RNA extraction from the tissue 
The RNA was extracted from an aliquot (not more than 30 mg) of the frozen 
kidney (-80°C), using the RNeasy Mini Kit (Qiagen, CA, USA). The total RNA 
from the animal cells was purified according to the manufacturer’s protocol and 
eluted in RNAse-free water. 
The concentration of the RNA was determined using absorbance at 260nm and 
RNA solution was stored at -80°C. 
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3.3 Reverse-transcription 
The extracted RNA was reverse transcribed using QuantiTec reverse 
transcription kit (Qiagen, CA, USA) according to the manufacturer’s protocol. 
Additional to the manufacturer’s protocol, negative controls, including RNase-
free water in place of the enzyme reverse transcriptase in the reverse-
transcription master mix, were prepared. These controls were used to estimate 
contamination with genomic DNA in RNA samples. 
The tubes with the cDNA and the corresponding negative controls were stored 
at -20°C. 
 
3.4 Quantification of steady-state gene-expression 
levels using quantitative real-time polymerase 
chain reaction 
 
To quantify the expression of the genes of interest, a two-step real time 
polymerase chain reaction (PCR) protocol was performed.  
The DNA-mix of each gene was diluted 1:10 prior to adding 10 l into the 
iQSYBER Green Supermix (Bio-Rad Laboratories, Hercules, CA), which 
was aliquoted onto a 96-well PCR array plate (15 l per well). 
A Bio-Rad iCycler (Bio-Rad Laboratories, Hercules, CA) was used for the 
thermal cycling and real-time detection: Activation of the hot start Taq 
polymerase for 3 min (95°C), followed by 45 cycles of denaturation at 95°C for 
15 sec (step 1) and annealing and extension at 60°C for 1 min (step 2). 
At the end of each extension step, fluorescence was detected by using 
fluorescent dye which binds double-stranded DNA molecules. 
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The identity and specificity of amplicons were confirmed by agarose gel 
electrophoresis, melting curve analysis and sequencing (Microsynth, Balgach, 
Switzerland). Relative amounts of each mRNA were normalized to the 
housekeeping gene β-actin and the steady-state mRNA expression levels were 
calculated using the ∆Ct-method and expressed as arbitrary units (AU) [118]. 
 
3.5 Agarose gel analysis 
To estimate amplicon seize and for sequencing, agarose gel electrophoresis 
was performed using PCR-products. 2%-agarose gel was prepared by melting 
2g agarose in 100ml boiling TBE buffer, adding 3µl ethidium bromide to the 
cooled solution and pouring it into the gel casting tray. Ethidium bromide is a 
fluorescent dye that intercalates between bases of nucleic acids and allows 
detection of DNA fragments in gels using UV light. The solidified gel was placed 
into an electrophoresis chamber and covered with a buffer solution. Prior to 
loading the DNA samples into the wells, the DNA was mixed with a loading dye. 
The loading dye increases the density of the DNA so it will sink into the well and 
it also works as a visual marker to ensure that the gel is running properly. 
Additionally to the DNA samples, a standard DNA sample with a DNA-ladder 
was loaded into one well. After all DNA samples have been loaded into the 
wells, the gel was run for 30 minutes with a constant voltage of 100 volts. The 
gel was now placed on an ultraviolet transilluminator to visualize the DNA and 
to compare the PCR amplicons with the DNA-ladder to estimate amplicon seize. 
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3.6 Extracting PCR products from agarose gel and 
sequencing 
 
For the extraction of the PCR products from agarose gel, first the specific area 
of the gel, containing the DNA, was cut and placed in a 2ml eppendorf. UV light 
was used to locate DNA bands. Then, according to the Qiagen gel extraction 
protocol DNA fragments were purified from gel.  
The purified DNA was send to Microsynth for sequencing. 
 
3.7 Primer design 
The primers used in the present study were designed using the software 
application Beacon designer® 2.06 (Premier Biosoft, Palo Alto, CA, USA). The 
sequences of the primers are shown in the appendix, chapter 7.2. 
 
3.8 Calculations and Statistical analyses 
For the statistical analyses and graphs, the StatView 5.0.1 (SAS Institute Inc., 
North Carolina, USA) was used. Because of the small n-numbers, normal 
distribution was assumed. Statistical significance was assessed by an unpaired 
t-Test. All the results are expressed as mean  standard error of the mean 
(SEM). Differences were considered statistically significant at p values  0.05. 
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4 Results 
4.1 Gene expression in kidneys of control animals 
In all experimental mice, the steady state renal mRNA expression of the 
analyzed genes was detected. The comparison of the relative expression levels 
in renal cortex of control-diet fed animals is shown in Figure 3. For illustration 
purpose the representation of the expression levels was separated in 3 groups: 
low, high and very high expression (Figure 3). Five genes of interest, NOS2, 
NOS3, Nox2; MCP-1, ICAM-1 and Atox1 belong to the low expression level 
group. NOS2 is the gene of interest with the lowest expression level (Figure 
3A). The second group, the high expression group, consists of p22phox, Nox4 
and SOD3 which were expressed at similar levels (>30-fold more to low 
expression group) (Figure 3B). SOD1, Gpx1 and Gpx3 belong to the third 
group, the very high expression group. Gpx3 is the gene of interest with the 
highest expression level (Figure 3C). 
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Figure 3. Steady state expression levels of renal NOS2, NOS3, Nox2, MCP-1, ICAM-1 and Atox1 (Panel 
A), p22phox, Nox4 and SOD3 (Panel B), SOD1, Gpx1 and Gpx3 (Panel C) in control animals. Values are 
mean±SEM and are expressed as arbitrary units=∆CT of gene of interest and housekeeping gene (n=6-7). 
(Note different scale y-axes A-C.) 
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4.2 Effects of diets on renal mRNA expression levels of 
genes coding for prooxidant and inflammatory 
enzymes 
4.2.1 Only Nox4 but not Nox2 and p22phox mRNA expression 
levels are affected by different dietary protocols 
 
As shown in Figure 4A, the expression level of Nox4 was significantly increased 
in all groups with a higher fat intake compared to the control group (P<0.05 vs 
CD). Fat intake had no significant effect on the expression levels of Nox2 and 
p22phox but a trend toward a higher Nox2 expression in the mice of the MFD 
group compared to the control group was detected (p=0.07 vs CD) (Panel B 
and C). 
 
  
Figure 4. Effects of control diet (CD), milk fat diet (MFD), coconut oil diet (COD) and milk fat/control diet 
(MFD/CD) on relative renal Nox4 mRNA expression (Panel A), relative Nox2 mRNA expression (Panel B) 
and relative renal p22phox mRNA expression (Panel C). Values are mean±SEM and are expressed as 
arbitrary units=∆CT of gene of interest and housekeeping gene (n=6-7). *=P<0.05 vs CD (Panel A)  
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4.2.2 Higher fat intake increases ICAM-1 but not MCP-1 mRNA 
expression levels 
 
In all mice groups fed with high fat diets an increased renal mRNA expression 
of ICAM-1 was observed (P<0.05 vs CD, figure 6A). Additionally, a trend toward 
a lower ICAM-1 expression in the mice of the MFD/CD group compared to the 
MFD group was detected (P=0.11). 
The increased fat intake had no significant effect on the expression of MCP-1 
within the groups (Figure 6B), but a strong trend towards a higher MCP-1 
expression in the MFD group was detected (P=0.051 vs CD). 
           ICAM-1 
 
 
         MCP-1 
 
 
Figure 6. Effects of control diet (CD), milk fat diet (MFD), coconut oil diet (COD) and milk fat/control diet 
(MFD/CD) on relative renal ICAM-1 mRNA expression (Panel A) and relative MCP-1 mRNA expression 
(Panel B). Values are mean±SEM and are expressed as arbitrary units=∆CT of gene of interest and 
housekeeping gene (n=5-7). *=P<0.05 vs CD (Panel A)  
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4.3 Effects of diets on renal gene expression levels of 
genes coding for antioxidant enzymes and coding 
for NOS 
4.3.1 Gene expression of SOD1 and SOD3 are not regulated by 
dietary fat intake 
 
The different dietary protocols had no effect on the expression levels of SOD1 
and SOD3 in renal cortex (Figure 8A and 8B). 
 
 
 
Figure 8. Effects of control diet (CD), milk fat diet (MFD), coconut oil diet (COD) and milk fat/control diet 
(MFD/CD) on relative renal SOD1 mRNA expression (Panel A) and relative SOD3 mRNA expression 
(Panel B). Values are mean±SEM and are expressed as arbitrary units=∆CT of gene of interest and 
housekeeping gene (n=5-7).  
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4.3.2 Milk fat diet increases the expression of Gpx1 but not of 
Gpx3 
 
Figure 7A shows a significantly increased expression level of Gpx1 in the MFD 
and the MFD/CD group (P<0.05 vs CD) and a trend to an increased Gpx1 
expression level in the COD group (P=0.055). The fat intake had no significant 
effect on the expression levels of Gpx3 (Figure 7B). 
 
 
 
 
 
Figure 7. Effects of control diet (CD), milk fat diet (MFD), coconut oil diet (COD) and milk fat/control diet 
(MFD/CD) on relative renal Gpx1 mRNA expression (Panel A) and relative Gpx3 mRNA expression (Panel 
B). Values are mean±SEM and are expressed as arbitrary units=∆CT of gene of interest and 
housekeeping gene (n=5-7). *=P<0.05 vs CD (Panel A)  
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4.3.3 Coconut oil diet increases renal gene expression of Atox1 
 
The expression level of the copper chaperone Atox1 was significantly increased 
in renal cortex of COD group (P<0.05 vs CD), shown in Figure 9. 
 
 
 
Figure 9. Effects of control diet (CD), milk fat diet (MFD), coconut oil diet (COD) and milk fat/control diet 
(MFD/CD) on relative renal Atox1 mRNA expression. Values are mean±SEM and are expressed as 
arbitrary units=∆CT of gene of interest and housekeeping gene (n=6-7). *=P<0.05 vs CD 
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4.3.4 Strong trend to a higher renal gene expression of NOS3 in 
all mice with a higher fat intake 
 
As shown in Figure 5A, in the group fed with MFD/CD diet NOS3 mRNA was 
significantly higher (P<0.05 vs CD). The COD and the MFD diet had no 
significant effect on the expression of NOS3 but a strong trend towards a higher 
gene expression was detected (P=0.06 and P=0.08 vs CD). The fat intake had 
no significant effect on the expression level of NOS2 (Figure 5B). 
 
     NOS3 
 
   NOS2 
   
Figure 5. Effects of control diet (CD), milk fat diet (MFD), coconut oil diet (COD) and milk fat/control diet 
(MFD/CD) on relative renal NOS3 mRNA expression (Panel A) and relative NOS2 mRNA expression 
(Panel B). Values are mean±SEM and are expressed as arbitrary units=∆CT of gene of interest and 
housekeeping gene (n=6-7). *=P<0.05 vs CD (Panel A) 
0
5
10
15
20
CD MFD COD MFD/CD
 m
R
N
A
 (
A
U
) 
* 
 A p=0.08 p=0.06 
0
1
2
3
4
CD MFD COD MFD/CD
 m
R
N
A
 (
A
U
) 
B 
Discussion 
43 
 
5 Discussion 
The present study shows that high-fat diet intake is associated with increased 
mRNA expression levels of genes coding for prooxidant and inflammatory 
enzymes (NAD(P)H oxidases, ICAM-1 and MCP-1) in the renal cortex of 
C57BL/6 mice. Furthermore, a trend to an upregulation of the antioxidant 
system in mice fed with high-fat diet was detected. There was no difference 
between the diet high in animal fat and the diet high in plant fat on the 
expression level of genes coding for prooxidant or antioxidant enzymes. A trend 
toward a reduction of the ICAM-1 expression after caloric restriction suggests 
that high fat diet induced oxidative stress may be reversible.  
 
5.1 High-fat diet induced oxidative stress in the kidney: 
Expression of renal NAD(P)H oxidases, ICAM-1 and 
MCP-1 in mice fed with high fat diet 
 
Oxidative stress and inflammation play an important role in the obesity related 
renal injury [119]. It has been demonstrated, that high fat diet induces 
histological changes in kidney such as mesangial space expansion in the 
glomeruli, collagen deposits, fibrosis, interstitial scarring and thickening basal 
membranes [120]. Fibrosis and scarring are dependent of numerous factors 
such as growth factors, cytokines and oxidative stress [35,120]. Therefore, the 
histological changes can be linked to the low grade inflammation existing in 
state of obesity [38] and the elevated oxidative stress and inflammation in 
kidney after high-fat diet [119,120]. Additionally, oxidative stress plays an 
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important role in renal damage associated with cardiovascular diseases through 
increased vascular inflammation and it has been demonstrated that oxidative 
stress activates the inflammatory cytokine NF-ĸB [121]. NF-ĸB activates the 
transcription of downstream inflammatory cytokines and chemokines which 
leads to infiltration of monocytes into tissue. These monocytes differentiate into 
macrophages and release additional chemokines which perpetuates the 
inflammation [121,122].  
In this study, as indicator for oxidative stress and inflammation, the mRNA 
expression levels of the NAD(P)H oxidase subunits Nox2, Nox4 and p22phox 
as well as the mRNA expression levels of ICAM-1 and MCP-1 were measured. 
 
NAD(P)H oxidases 
Several studies showed that the multi-subunit enzyme NAD(P)H oxidase is the 
predominant source of ROS production in renal cortex [44,45,123]. Various 
NAD(P)H oxidase subunits are expressed in blood vessels, interstitial cells, 
glomeruli and tubule of the kidney [123]. The non-phagocyte Nox4-enzyme, a 
homolog of the prototypical NAD(P)H oxidase Nox2, is the predominant Nox 
isoform expressed in the renal cortex [52,123].  
The non-phagocytic NAD(P) oxidase Nox4 is structurally related to Nox2 but 
there exist some functional differences between those two oxidases [56] : Nox4 
generates constitutively low levels of O2
- which are much lower than the O2
- 
production of Nox2, even after stimulation [56]. A substantial proportion of ROS 
produced by Nox4 seems to be intracellular while ROS produced by Nox2 occur 
in the extracellular space [56]. An upregulation of the Nox4 level leads to an 
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increased ROS production resulting in morphological changes of the kidney, 
including glomerular hypertrophy, fibrosis and interstitial scarring [124].  
Nox4, abundant expressed in distal tubular cells, has the additional function as 
an oxygen sensor and an influence on the expression of erythropoietin (EPO) 
[52]. EPO is the primary regulator of the erythropoiesis and stimulates the 
production of red blood cells [125]. Superoxide and its derivative ROS, 
produced by Nox4, destabilize HIF-1α, a dominant transcriptional activator of 
the gene for EPO. This inactivation of HIF-1α leads to a decreased EPO 
expression [52,126]. 
In a healthy condition, superoxide and its derivative ROS are formed by Nox4 
proportional to local oxygen concentrations. Hence, a high oxygen 
concentration leads to a reduction of EPO expression [52]. 
The present study shows a significant upregulation of Nox4 mRNA level in renal 
cortex of mice fed with high fat diet. This finding is supported by a study of 
Ruggiero et al. which demonstrated an increase of Nox4 expression in the 
kidney of mice fed with high fat diet for 12 or 16 weeks [120].  
As mentioned above, an increased expression of Nox4 and the associated 
elevated ROS production leads to a diminished EPO production. Since EPO is 
essential for a sufficient erythropoiesis, it can be hypothesized that an 
upregulation of Nox4 over an extended time span, as it exists in state of obesity, 
could cause an anemia. 
Mice treated with high fat diet showed a trend to an upregulated Nox2 level. As 
mentioned above, there are several differences between Nox2 and Nox4: Nox2 
has a stronger influence on the extracellular ROS level especially on ROS 
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peaks. This may suggest that an even a small upregulated Nox2 level has 
already a high impact on the proinflammatory state and creates more structural 
damage of the kidney during obesity. 
On the third tested prooxidant, p22phox, the high fat diets had no significant 
effect. This result is comparable to the study of Simo et al. which found no 
significant difference in p22phox expression between age-matched groups of 
normotensive Wistar Kyoto rats and spontaneously hypertensive rats even 
though the Nox4 expression was elevated in the hypertensive rats [127]. 
p22phox is not only a subunit of the NAD(P)-oxidase, it is also a subunit of 
cytochrom b which is a component of the respiratory chain in the mitochondrion 
[128]. An elevation of the p22phox unit specifically associated with the 
NAD(P)H-oxidase in mice fed with high fat diet cannot be excluded as overall 
expression levels were detected and possible changes in association with 
different complexes remain unclear. 
 
ICAM-1 and MCP-1 
ICAM-1 as well as MCP-1 mediate transmigration and chemotaxis of monocytes 
and macrophages into sites of inflammation [59]. ICAM-1 and MCP-1 levels are 
upregulated in inflammatory conditions by several cytokines such as TNF or Il-6 
[59,129,130]. These cytokines are among others produced by adipose tissue, 
which exists in a great measure in a state of obesity [19,20]. But not only 
cytokines, also ROS, especially hydrogen peroxide (H2O2) induces ICAM-1 
expression [131]. It is known that upregulation of ICAM-1 in the kidney of mice 
is associated with infiltration of leukocytes (mainly macrophages), mesangial 
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matrix expansion and accumulation of type IV collagen. These promote 
glomerulosclerosis [132].  
The present study shows a significant elevation of the renal ICAM-1 mRNA 
level in all mice with a higher fat intake. This could be a consequence of the 
increased Nox4 expression in the obese kidney. Additionally, a trend toward a 
normalization of the ICAM-1 level after changing the milk fat diet (animal fat) to 
normal diet is observed. The high fat diets had no significant effect to the MCP-
1 expression level but a trend to an increased MCP-1 expression in the group of 
mice fed with milk fat diet was detected.  
Taking together, the trends of Nox2 and MCP-1 suggests that a high-fat diet 
based on milk fat may pose a greater risk for impairment of renal function and 
morphological renal changes than a high-fat diet based on coconut oil.  
  
Discussion 
48 
 
5.2 Renal expression levels of antioxidant enzymes and 
NOS after high fat diet feeding 
 
Glutathione peroxidases 
The intracellular glutathione peroxidase Gpx1 is ubiquitously expressed in 
humans and plays an essential role in the defense against oxidative stress [90]. 
Gpx1 reduces organic hydroperoxides and can protect biomembranes against 
spontaneous lipid peroxidation which is likely mediated by H2O2 [133]. In 
healthy kidney, Gpx1 is the major isoform of the glutathione peroxidases and is 
responsible for 96% of Gpx-activity in kidney. Therefore, Gpx1 plays a central 
role in the ability of the kidney to cope with oxidative stress [134]. 
The present study demonstrates a significant increase of Gpx1 expression 
following a diet high in milk fat. These results stay in line with the study of Fujita 
et al. which demonstrated an upregulation of Gpx1 expression in the kidney of 
obese diabetic KKAy mice [135].  
Since Gpx1 is the dominant antioxidant enzyme in the kidney, the significant 
upregulation in all mice with a diet high fat agrees with the expectation that an 
increased Gpx1 level acts as a compensatory mechanism to keep ROS levels 
under control. In mice fed with coconut oil diet, it was not possible to detect a 
significant effect but a trend to a higher Gpx1 level is demonstrated. The 
significant upregulated Gpx1 in the MFD group and the trend to a higher level of 
Gpx1 in the COD group suggest that Gpx1 plays a compensatory role by an 
upregulation of the antioxidant system. Furthermore, the non-significant 
upregulation of the Gpx1 in COD group supports the above formulated 
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hypothesis, based on the measurements of Nox2 and MCP-1, that a diet high in 
plant fat is less harmful than a diet high in animal fat. 
 
SOD1, SOD3 and Atox1 
In the present study the antioxidant enzymes SOD1 and SOD3 were 
investigated. None of the high-fat diet had an effect on the mRNA expression 
level of SOD1 or SOD3 in renal cortex of mice. These results are consistent 
with the findings of Coate et al., demonstrating that a 16 weeks treatment with 
high fat diet had no effect on the SOD expression in adipose tissue of male 
C57BL/6 mice [136]. In contrast, Roberts et al. showed a downregulation of 
SOD expression in the kidney of Fischer rats treated with a high fat diet [27]. 
The study of Furukawa et al. demonstrated a decreased expression of the 
antioxidant enzymes SOD in adipose tissue of obese mice, but not so in the 
liver and in skeletal muscles [26]. These variable results can be explained by 
the different animal models and different dietary protocols used in the studies. 
For clarification, it would be necessary to investigate the organ-specific 
expression of SOD in further studies. 
The present study shows a significant higher expression of the copper chaperon 
Atox1 following the diet high in coconut oil but no change in the expression level 
following the milk fat diet. Atox1 is a copper chaperon for SOD3 and a positive 
regulator for SOD3 transcription [100]. This suggests that an upregulation of 
Atox1 can lead to a higher expression of SOD3. In this study, the increased 
expression of Atox1 in the COD group was not associated with an elevated 
expression of SOD3, which is not in accordance with the study of Jeney et al. 
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The discrepancy could be explained by the different experimental protocol used 
in the study: Jeney et al. compared Atox1 knockout animals to wild-type animals 
which showed a large difference in the Atox1 expression-level between the 
groups [100]. Whereas, the change in the Atox1 expression-level detected in 
this study may not be high enough to have an effect on the SOD3 expression. 
 
NOS3 and NOS2 
Nitric oxide synthases catalyze the nitric oxide synthesis [101]. Nitric oxide is 
important for the reduction of oxidative stress by scavering ROS [116]. 
Additionally, it plays an important role in renal physiology by regulating local 
arteriolar tone, tubular sodium handling and mesangial cell proliferation and 
hence has an anti-fibrotic effect in the kidney [107]. Endothelial NOS, NOS3, is 
expressed in endothelial cells of renal vasculature and glomeruli [137]. The 
present study shows a strong trend to a higher expression of NOS3 in the renal 
cortex of all mice with a higher fat intake. This effect can be interpreted as a 
compensatory reaction on the increased ROS production and impaired NO 
concentration (by scavenging ROS) which may be partly caused by the 
significant enhanced Nox4 expression (see above). In contrast to this result, 
previous studies showed no effect on the expression level of NOS3 in the 
kidney cortex of rats fed with moderately high-fat diet and also no effect on the 
expression level of vascular NOS3 of rats or mice fed with high fat diet [138-
140]. Since nitric oxide produced by NOS plays an important role in protecting 
kidney from glomerulosclerosis [115], further investigations concerning kidney-
specific nitric oxide production would be of interest. 
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The different dietary protocols had no effect on the expression level of the 
inducible NOS, the NOS2.  
5.3 Limitations of the study 
The body weight data of the mice were not available for the present study. 
Therefore, it remains unclear whether diets led to changes in weight. 
Histological data of the kidneys are missing which could give insight into 
possible structural changes in the kidneys. Measurements of oxidative stress 
such as ROS levels are missing. These data would provide evidence whether 
the change in mRNA expression levels translate to changes in renal ROS 
levels. 
 
5.4 Clinical implications 
The finding that ROS is linked to the development of different diseases leads to 
the consideration, that an improvement of the antioxidant system may prevent 
diseases and mortality. Additional to the enzymatic antioxidants, there are non-
enzymatic antioxidants like the vitamins A, C and E, glutathione, α-lipoic acid, 
mixed carotenoids, coenzyme Q10, several bioflvonoids, antioxidant minerals 
and cofactors like folic acid, uric acid, albumin and vitamins B1, B2, B6 and B12 
[141]. Many studies were conducted with the aim to show a beneficial effect on 
morbidity and mortality through antioxidant supplements like beta-carotene, 
vitamin A, vitamin C, vitamin E or selenium [141,142]. Some evidence for a 
protective effect of antioxidants in treating diabetes and its complications is 
demonstrated [141] but there is no evidence that antioxidant supplements have 
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a beneficial effect in primary or secondary prevention of mortality in adults [142]. 
Surprisingly, supplementation of beta-carotene, vitamin E and higher dose of 
vitamin A can even increase mortality by increasing the risk of cancer and 
cardiovascular diseases [142,143].  
Since antioxidant supplements, including vitamins, do not display an 
advantageous effect and can even increase mortality, they should be 
considered as medical products and need to be sufficient evaluated before 
distributing freely to the general population. 
 
5.5 Conclusion 
The present study showed that a higher fat intake has an influence on the 
expression of prooxidant and antioxidant enzymes. This study could not 
demonstrate that these effects are reversible by diet normalization. It has to be 
considered that different conditions, for example a longer treatment duration, 
may lead to different results. Since the reversibility of the upregulation of the 
prooxidant system is the important factor for the success of a nutritional regime, 
further investigations in this direction would be of great value.  
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7 Appendix 
7.1  Reverse-transcription 
 
Reverse-transcription master mix: 
1µl Quantiscript Reverse Transcriptase®: Reverse Transcriptase, also 
containing an RNase Inhibitor 
(Qiagen, Hilden, Germany) 
4µl Quantiscript RT Buffer®: Deoxynucleotid-triphosphate 
(Qiagen, Hilden, Germany) 
1µl RT Primer Mix®:  oligo-dT and random primers 
(Qiagen, Hilden, Germany) 
 
 
7.2 Polymerase chain reaction 
 
PCR master mix: 
12.5µl SYBR green (Qiagen, Hilden, Germany) 
9.5µl RNase free water 
0.5µl Primer forward (Microsynth) - (10µM in well) 
0.5µl Primer reverse (Microsynth) 
2µl template cDNA 
 
PCR experiments were run on the iQ™ iCycler (Bio-Rad, Reinach, Switzerland) 
using specific cDNA primers (Microsynth, Balgach, Switzerland). 
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Primerlist: 
Gene Name 
Accession number 
Forward Primer 
Reverse Primer 
Product size  
(bp) 
 
Atox1 
NM_009726 
 
5’-GCT CTT CTC CAC AAT GCT AAC C-3’ 
5’-CTT AAC ACC AGT CAC ACC CTT G-3’ 
 
135 
 
Beta-actin  
X03672 
 
5’-CGT GCG TGA CAT CAA AGA GA-3’ 
5’-CCC AAG AAG GAA GGC TGG A-3’ 
 
180 
 
Gpx1 
NM_008160 
 
5’-TCA GTT CGG ACA CCA GGA GAA-3’ 
5’-CTC ACC ATT CAC TTC GCA CTT C-3’ 
 
124 
 
Gpx3 
NM_008161 
 
5’-CTT GGT CAT TCT GGG CTT CC-3’ 
5’-CCC GTT CAC ATC TCC TTT CTC-3’ 
 
148 
 
ICAM-1 
NM_010493 
 
5’-GAC GCA GAG GAC CTT AAC AG-3’ 
5’-GAC GCC GCT CAG AAG AAC-3’ 
 
139 
 
MCP-1 
NM_011333 
 
5’-GGT CCC TGT CAT GCT TCT G-3’ 
5’-CAT CTT GCT GGT GAA TGA GTA G-3’ 
 
121 
 
NOS2  
NM_010927 
 
5’-GCA CCG AGA TTG GAG TTC-3’ 
5’ AGC ACA GCC ACA TTG ATC-3’ 
 
110 
 
NOS3 
NM_008713 
 
5’-CCT AGT CCT CGC CTC CTT C-3’ 
5’-ACC ACT TCC ATT CTT CGT AGC-3’ 
 
112 
 
Nox2 
U43384 
 
5’-AAC TCC TTG GGT CAG CAG TG-3’ 
5’-GAG CAA CAC GCA CTG GAA C-3’ 
 
130 
 
Nox4 
NM_015760 
 
5’-GTG AAG ATT TGC CTG GAA GAA C-3’ 
5’-TGA TGA CTG AGA TGA TGG TGA C-3’ 
 
148 
 
p22phox 
NM_00786 
 
5’-GTG GAC TCC CAT TGA GCC TA-3’ 
5’-CTC CTC TTC ACC CTC ACT CG-3’ 
 
130 
 
SOD1  
M35725 
 
5’-TGG GTT CCA CGT CCA TCA GTA-3’ 
5’-ACC GTC CTT TCC AGC AGT CA-3’ 
 
151 
 
SOD3 
NM_011435 
 
5’-TTG TTC TAC GGC TTG CTA CTG-3’ 
5’-CGT GTC GCC TAT CTT CTC AAC-3’ 
 
141 
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